Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trial.
Zhao Y, Guan C, Wang Y, Jin Z, Yu B, Fu G, Chen Y, Guo L, Qu X, Zhang Y, Dou K, Wu Y, Yang W, Tu S, Escaned J, Fearon W, Qiao S, Cohen D, Krumholz H, Xu B, Song L. Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trial. Chinese Medical Journal 2025 PMID: 40025631, DOI: 10.1097/cm9.0000000000003484.Peer-Reviewed Original ResearchIncremental cost-effectiveness ratioPercutaneous coronary interventionQuality-adjusted life yearsQuantitative flow ratioQFR-guided strategyClinical outcomesReduced rate of MACCEsChinese healthcare systemTwo-year clinical outcomesAngiography-based approachHealthcare systemAngiography-guided groupTwo-year follow-upRate of MACCEAngiography-guided strategyReference vessel diameterCardiovascular medication useCost-effectiveness ratioPost-myocardial infarctionFractional flow reserveTwo-year costsAngiography guidanceSham-controlled trialCost-utility analysisCerebrovascular events
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply